Article
Addressing the need to tailor treatment to the spectrum of type 2 diabetes: new perspectives.
Diabetes technology & therapeutics - 1 May 2009
Rolla Arturo R
Abstract excerpt
Type 2 diabetes mellitus is characterized by the progressive loss of beta cell function, which occurs after many years of insulin resistance. Within this definition, clinicians may see a diverse array of presentations, suggesting different proportions of these two pathogenic factors and a complex etiology. There are also differences in the rate of type 2 diabetes progression in each patient, so treatments must be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
